Toll-like receptors: their roles in bacterial recognition and respiratory infections

References

• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol.21(1), 335–376 (2003).
   PubMed Web of Science ®Google Scholar
• Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophila, required for dorsal–ventral embryonic polarity, appears to encode a transmembrane protein. Cell52(2), 269–279 (1988).
   PubMed Web of Science ®Google Scholar
• Lemaitre B, Nicolas E, Michaut L, Reichhart J-M, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell86(6), 973–983 (1996).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388(6640), 394–397 (1997).
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science282(5396), 2085–2088 (1998).
   PubMed Web of Science ®Google Scholar
• Beutler B, Rehli M. Evolution of the TIR, Tolls and TLRs: functional inferences from computational biology. Curr. Top. Microbiol. Immunol.270, 1–21 (2002).
   PubMed Web of Science ®Google Scholar
• Imler J-L, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol.11(7), 304–311 (2001).
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A, Hajjar AM et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature401(6755), 811–815 (1999).
   PubMed Web of Science ®Google Scholar
• Anderson KV. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol.12(1), 13–19 (2000).
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. TLR signaling pathways. Semin. Immunol.16(1), 3–9 (2004).
   PubMed Web of Science ®Google Scholar
• O’Neill LAJ, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol.7(5), 353–364 (2007).
   PubMed Web of Science ®Google Scholar
• Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem.76(1), 141–165 (2007).
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol.6(9), 644–658 (2006).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Kopp E et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell2(2), 253–258 (1998).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science301(5633), 640–643 (2003).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol.4(11), 1144–1150 (2003).
   PubMed Web of Science ®Google Scholar
• Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature424(6950), 743–748 (2003).
   PubMed Web of Science ®Google Scholar
• Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by TRIF-dependent and TRIF-independent pathways. Nat. Immunol.4(12), 1223–1229 (2003).
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol.5(10), 987–995 (2004).
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol.7(12), 1237–1242 (2006).
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol.117(5), 979–987 (2006).
   PubMed Web of Science ®Google Scholar
• Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature430(6996), 257–263 (2004).
   PubMed Web of Science ®Google Scholar
• Ting JPY, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol.8(5), 372–379 (2008).
   PubMed Web of Science ®Google Scholar
• Kanneganti T-D, Lamkanfi M, Núñez G. Intracellular NOD-like receptors in host defense and disease. Immunity27(4), 549–559 (2007).
   PubMed Web of Science ®Google Scholar
• Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature442(7098), 39–44 (2006).
   PubMed Web of Science ®Google Scholar
• Creagh EM, O’Neill LAJ. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol.27(8), 352–357 (2006).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol.2(8), 675–680 (2001).
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol.14(1), 103–110 (2002).
   PubMed Web of Science ®Google Scholar
• Ishii K, Coban C, Akira S. Manifold mechanisms of Toll-like receptor–ligand recognition. J. Clin. Immunol.25(6), 511–521 (2005).
   PubMed Web of Science ®Google Scholar
• Bell JK, Botos I, Hall PR et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl Acad. Sci. USA102(31), 10976–10980 (2005).
   PubMed Web of Science ®Google Scholar
• Choe J, Kelker MS, Wilson IA. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science309(5734), 581–585 (2005).
   PubMed Web of Science ®Google Scholar
• Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl Acad. Sci. USA97(25), 13766–13771 (2000).
   PubMed Web of Science ®Google Scholar
• Underhill DM. Toll-like receptors: networking for success. Eur. J. Immunol.33(7), 1767–1775 (2003).
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, Rowe DC, Golenbock DT. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect.6(15), 1361–1367 (2004).
   PubMed Web of Science ®Google Scholar
• Kimoto M, Nagasawa K, Miyake K. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand. J. Infect. Dis.35(9), 568–572 (2003).
   PubMed Web of Science ®Google Scholar
• Kim HM, Park BS, Kim J-I et al. Crystal structure of the TLR4–MD-2 complex with bound endotoxin antagonist eritoran. Cell130(5), 906–917 (2007).
   PubMed Web of Science ®Google Scholar
• Ohto U, Fukase K, Miyake K, Satow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science316(5831), 1632–1634 (2007).
   PubMed Web of Science ®Google Scholar
• Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res.8(6), 459–463 (2002).
   PubMedGoogle Scholar
• Jin MS, Kim SE, Heo JY et al. Crystal structure of the TLR1–TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell130(6), 1071–1082 (2007).
   PubMed Web of Science ®Google Scholar
• Qureshi ST, Lariviere L, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med.189(4), 615–625 (1999).
   PubMed Web of Science ®Google Scholar
• Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol.162(7), 3749–3752 (1999).
   PubMed Web of Science ®Google Scholar
• Beutler B. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol.270, 109–120 (2002).
   PubMed Web of Science ®Google Scholar
• Vasselon T, Detmers PA, Charron D, Haziot A. TLR2 recognizes a bacterial lipopeptide through direct binding. J. Immunol.173(12), 7401–7405 (2004).
   PubMed Web of Science ®Google Scholar
• Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science285(5428), 732–736 (1999).
   PubMed Web of Science ®Google Scholar
• Faure E, Equils O, Sieling PA et al. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of Tlr-4 and Tlr-2 in endothelial cells. J. Biol. Chem.275(15), 11058–11063 (2000).
   PubMed Web of Science ®Google Scholar
• Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem.274(25), 17406–17409 (1999).
   PubMed Web of Science ®Google Scholar
• Tapping RI, Tobias PS. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin Res.9(4), 264–268 (2003).
   PubMedGoogle Scholar
• Buwitt-Beckmann U, Heine H, Wiesmuller KH et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol.35(1), 282–289 (2005).
   PubMed Web of Science ®Google Scholar
• Buwitt-Beckmann U, Heine H, Wiesmuller KH et al. TLR1- and TLR6-independent recognition of bacterial lipoeptides. J. Biol. Chem.281, 9049–9057 (2006).
   PubMed Web of Science ®Google Scholar
• Morr M, Takeuchi O, Akira S, Simon MM, Mühlradt PF. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur. J. Immunol.32(12), 3337–3347 (2002).
   PubMed Web of Science ®Google Scholar
• Okusawa T, Fujita M, Nakamura J et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect. Immun.72(3), 1657–1665 (2004).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Kawai T, Muhlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol.13(7), 933–940 (2001).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Sato S, Horiuchi T et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol.169(1), 10–14 (2002).
   PubMed Web of Science ®Google Scholar
• Hajjar AM, O’Mahony DS, Ozinsky A et al. Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol.166(1), 15–19 (2001).
   PubMed Web of Science ®Google Scholar
• Johnson CM, Lyle EA, Omueti KO et al. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol.178(12), 7520–7524 (2007).
   PubMed Web of Science ®Google Scholar
• Travassos LH, Girardin SE, Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep.5(10), 1000–1006 (2004).
   PubMed Web of Science ®Google Scholar
• Dziarski R, Gupta D. Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun.73(8), 5212–5216 (2005).
   PubMed Web of Science ®Google Scholar
• Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature410(6832), 1099–1103 (2001).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature408(6813), 740–745 (2000).
   PubMed Web of Science ®Google Scholar
• Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA98(16), 9237–9242 (2001).
   PubMed Web of Science ®Google Scholar
• Kollisch G, Kalali BN, Voelcker V et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology114(4), 531–541 (2005).
   PubMed Web of Science ®Google Scholar
• Pivarcsi A, Bodai L, Rethi B et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol.15(6), 721–730 (2003).
   PubMed Web of Science ®Google Scholar
• Miller LS, Modlin RL. Human keratinocyte Toll-like receptors promote distinct immune responses. J. Invest. Dermatol.127(2), 262–263 (2007).
   PubMed Web of Science ®Google Scholar
• Lebre MC, van der Aar AMG, van Baarsen L et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol.127(2), 331–341 (2006).
   PubMed Web of Science ®Google Scholar
• Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol.174(8), 4453–4460 (2005).
   PubMed Web of Science ®Google Scholar
• Chabot S, Wagner JS, Farrant S, Neutra MR. TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J. Immunol.176(7), 4275–4283 (2006).
   PubMed Web of Science ®Google Scholar
• Uno K, Kato K, Atsumi T et al. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol.293(5), G1004–G1012 (2007).
   PubMed Web of Science ®Google Scholar
• Chen J, Rao JN, Zou T et al. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol.293(3), G568–G576 (2007).
   PubMed Web of Science ®Google Scholar
• Fazeli A, Bruce C, Anumba DO. Characterization of Toll-like receptors in the female reproductive tract in humans. Hum. Reprod.20(5), 1372–1378 (2005).
   PubMed Web of Science ®Google Scholar
• Palladino MA, Johnson TA, Gupta R, Chapman JL, Ojha P. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol. Reprod.76(6), 958–964 (2007).
   PubMed Web of Science ®Google Scholar
• Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol. Rev.173(1), 27–38 (2000).
   PubMed Web of Science ®Google Scholar
• Harju K, Glumoff V, Hallman M. Ontogeny of Toll-like receptors TLR2 and TLR4 in mice. Pediatr. Res.49(1), 81–83 (2001).
   PubMed Web of Science ®Google Scholar
• Armstrong L, Medford ARL, Uppington KM et al. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol.31(2), 241–245 (2004).
   PubMed Web of Science ®Google Scholar
• Hertz CJ, Wu Q, Porter EM et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human β defensin-2. J. Immunol.171(12), 6820–6826 (2003).
   PubMed Web of Science ®Google Scholar
• Guillot L, Le Goffic R, Bloch S et al. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem.280(7), 5571–5580 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Louboutin J-P, Weiner DJ, Goldberg JB, Wilson JM. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect. Immun.73(11), 7151–7160 (2005).
   PubMed Web of Science ®Google Scholar
• Platz J, Beisswenger C, Dalpke A et al. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol.173(2), 1219–1223 (2004).
   PubMed Web of Science ®Google Scholar
• Chaudhuri N, Dower SK, Whyte MKB, Sabroe I. Toll-like receptors and chronic lung disease. Clin. Sci.109(2), 125–133 (2005).
   Web of Science ®Google Scholar
• Soong G, Reddy B, Sokol S, Adamo R, Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest.113(10), 1482–1489 (2004).
   PubMed Web of Science ®Google Scholar
• Phipps S, Lam CE, Foster PS, Matthaei KI. The contribution of Toll-like receptors to the pathogenesis of asthma. Immunol. Cell Biol.85(6), 463–470 (2007).
   PubMed Web of Science ®Google Scholar
• Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol.1(5), 398–401 (2000).
   PubMed Web of Science ®Google Scholar
• Jones BW, Heldwein KA, Means TK, Saukkonen JJ, Fenton MJ. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis.60(90003), iii6–iii12 (2001).
   PubMed Web of Science ®Google Scholar
• Droemann D, Goldmann T, Tiedje T et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir. Res.6(1), 68 (2005).
   PubMed Web of Science ®Google Scholar
• Oshikawa K, Sugiyama Y. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem. Biophys. Res. Commun.305(3), 649–655 (2003).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suda T, Naito T et al. Impaired Toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. Am. J. Respir. Crit. Care Med.171(7), 707–713 (2005).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Berrington WR, Smith IA et al. Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila. J. Immunol.179(10), 6981–6987 (2007).
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Patel S et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med.205(2), 323–329 (2008).
   PubMed Web of Science ®Google Scholar
• Means TK, Hayashi F, Smith KD, Aderem A, Luster AD. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J. Immunol.170(10), 5165–5175 (2003).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Verbon A, Lettinga KD et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires’ disease. J. Exp. Med.198(10), 1563–1572 (2003).
   PubMed Web of Science ®Google Scholar
• Yu Y, Nagai S, Wu H et al. TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J. Immunol.176(10), 6194–6201 (2006).
   PubMed Web of Science ®Google Scholar
• Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J. Appl. Physiol.66(3), 1059–1064 (1989).
   PubMed Web of Science ®Google Scholar
• Kitz R, Rose MA, Borgmann A, Schubert R, Zielen S. Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects. J. Endotoxin Res.12(6), 367–374 (2006).
   PubMedGoogle Scholar
• Michel O, Nagy A-M, Schroeven M et al. Dose–response relationship to inhaled endotoxin in normal subjects. Am. J. Respir. Crit. Care Med.156(4), 1157–1164 (1997).
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Thorne PS, Jagielo PJ et al. Endotoxin responsiveness and grain dust-induced inflammation in the lower respiratory tract. Am. J. Physiol. Lung Cell. Mol. Physiol.267(5), L609–L617 (1994).
   PubMed Web of Science ®Google Scholar
• Lefort J, Singer M, Leduc D et al. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-α formation and neutrophil sequestration into the murine lungs. J. Immunol.161(1), 474–480 (1998).
   PubMed Web of Science ®Google Scholar
• Alexis NE, Lay JC, Almond M et al. Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo. J. Allergy Clin. Immunol.115(2), 345–350 (2005).
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Wohlford-Lenane CL, Quinn TJ, Krieg AM. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J. Immunol.163(1), 224–231 (1999).
   PubMed Web of Science ®Google Scholar
• Maris NA, Dessing MC, de Vos AF et al. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur. Respir. J.28(3), 622–626 (2006).
   PubMed Web of Science ®Google Scholar
• Eisenbarth SC, Piggott DA, Huleatt JW et al. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med.196(12), 1645–1651 (2002).
   PubMed Web of Science ®Google Scholar
• Jeon SG, Oh S-Y, Park H-K et al. Th2 and Th1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. J. Allergy Clin. Immunol.120(4), 803–812 (2007).
   PubMed Web of Science ®Google Scholar
• Leemans JC, Vervoordeldonk MJBM, Florquin S, van Kessel KP, van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am. J. Respir. Crit. Care Med.165(10), 1445–1450 (2002).
   PubMed Web of Science ®Google Scholar
• Leemans JC, Heikens M, van Kessel KPM, Florquin S, van der Poll T. Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice. Clin. Diagn. Lab. Immunol.10(5), 950–953 (2003).
   PubMedGoogle Scholar
• Adamo R, Sokol S, Soong G, Gomez MI, Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialo GM1 and Toll-Like receptor 2 as well as Toll-like receptor 5. Am. J. Respir. Cell Mol. Biol.30(5), 627–634 (2004).
   PubMed Web of Science ®Google Scholar
• Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect. Immun.72(11), 6676–6679 (2004).
   PubMed Web of Science ®Google Scholar
• Feuillet V, Medjane S, Mondor I et al. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl Acad. Sci. USA103(33), 12487–12492 (2006).
   PubMed Web of Science ®Google Scholar
• Pons J, Sauleda J, Regueiro V et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir. Res.7(1), 64 (2006).
   PubMedGoogle Scholar
• WHO. The world health report 1999: making a difference. World Health Organization, Geneva, Switzerland (1999).
   Google Scholar
• Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle72(1), 1–6 (1991).
   PubMedGoogle Scholar
• WHO. Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva, Switzerland (2006).
   Google Scholar
• Dye C, Scheele S, Dolin P et al. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA282(7), 677–686 (1999).
   PubMed Web of Science ®Google Scholar
• Schlesinger L. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol.150(7), 2920–2930 (1993).
   PubMed Web of Science ®Google Scholar
• Stokes RW, Haidl ID, Jefferies WA, Speert DP. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J. Immunol.151(12), 7067–7076 (1993).
   PubMed Web of Science ®Google Scholar
• Swartz RP, Naai D, Vogel CW, Yeager H Jr. Differences in uptake of mycobacteria by human monocytes: a role for complement. Infect. Immun.56(9), 2223–2227 (1988).
   PubMed Web of Science ®Google Scholar
• Zaffran Y, Zhang L, Ellner JJ. Role of CR4 in Mycobacterium tuberculosis–human macrophages binding and signal transduction in the absence of serum. Infect. Immun.66(9), 4541–4544 (1998).
   PubMed Web of Science ®Google Scholar
• Armstrong J, Hart P. Phagosome–lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med.142, 1–16 (1975).
   PubMed Web of Science ®Google Scholar
• Kang BK, Schlesinger LS. Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect. Immun.66(6), 2769–2777 (1998).
   PubMed Web of Science ®Google Scholar
• Kang PB, Azad AK, Torrelles JB et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med.202(7), 987–999 (2005).
   PubMed Web of Science ®Google Scholar
• Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun.66(4), 1277–1281 (1998).
   PubMed Web of Science ®Google Scholar
• Ferguson JS, Schlesinger LS. Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis. Tuber. Lung Dis.80(4–5), 173–184 (2000).
   PubMedGoogle Scholar
• Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol.163(1), 312–321 (1999).
   PubMed Web of Science ®Google Scholar
• Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J. Immunol.168(3), 1309–1314 (2002).
   PubMed Web of Science ®Google Scholar
• Gaynor C, McCormack F, Voelker D, McGowan S, Schlesinger L. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol.155(11), 5343–5351 (1995).
   PubMed Web of Science ®Google Scholar
• Koppel EA, van Gisbergen KPJM, Geijtenbeek TBH, van Kooyk Y. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell. Microbiol.7(2), 157–165 (2005).
   PubMed Web of Science ®Google Scholar
• Tailleux L, Maeda N, Nigou J, Gicquel B, Neyrolles O. How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. Trends Microbiol.11(6), 259–263 (2003).
   PubMed Web of Science ®Google Scholar
• Peterson P, Gekker G, Hu S et al. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun.63(4), 1598–1602 (1995).
   PubMed Web of Science ®Google Scholar
• Fratazzi C, Manjunath N, Arbeit RD et al. A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J. Exp. Med.192(2), 183–192 (2000).
   PubMed Web of Science ®Google Scholar
• Randhawa AK, Ziltener HJ, Merzaban JS, Stokes RW. CD43 is required for optimal growth inhibition of Mycobacterium tuberculosis in macrophages and in mice. J. Immunol.175(3), 1805–1812 (2005).
   PubMed Web of Science ®Google Scholar
• Leemans JC, Florquin S, Heikens M et al. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J. Clin. Invest.111(5), 681–689 (2003).
   PubMed Web of Science ®Google Scholar
• Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol.6, 33–43 (2006).
   PubMed Web of Science ®Google Scholar
• Yadav M, Schorey JS. The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood108(9), 3168–3175 (2006).
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Modlin RL. The role of Toll-like receptors in combating mycobacteria. Semin. Immunol.16(1), 35–41 (2004).
   PubMed Web of Science ®Google Scholar
• Ryffel B, Fremond C, Jacobs M et al. Innate immunity to mycobacterial infection in mice: critical role for Toll-like receptors. Tuberculosis85(5–6), 395–405 (2005).
   PubMed Web of Science ®Google Scholar
• van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev.15(2), 294–309 (2002).
   PubMed Web of Science ®Google Scholar
• Quesniaux V, Fremond C, Jacobs M et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect.6(10), 946–959 (2004).
   PubMed Web of Science ®Google Scholar
• Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect.4(9), 937–944 (2002).
   PubMed Web of Science ®Google Scholar
• Means TK, Wang S, Lien E et al. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol.163(7), 3920–3927 (1999).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Sato S, Horiuchi T et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol.169(1), 10–14 (2002).
   PubMed Web of Science ®Google Scholar
• Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol.167(2), 987–994 (2001).
   PubMed Web of Science ®Google Scholar
• Bafica A, Scanga CA, Feng CG et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med.202(12), 1715–1724 (2005).
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl Acad. Sci. USA96(25), 14459–14463 (1999).
   PubMed Web of Science ®Google Scholar
• Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J. Immunol.177(1), 422–429 (2006).
   PubMed Web of Science ®Google Scholar
• MacMicking JD, North RJ, LaCourse R et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl Acad. Sci. USA94(10), 5243–5248 (1997).
   PubMed Web of Science ®Google Scholar
• Scanga CA, Bafica A, Feng CG et al. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun.72(4), 2400–2404 (2004).
   PubMed Web of Science ®Google Scholar
• Fremond CM, Yeremeev V, Nicolle DM et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest.114(12), 1790–1799 (2004).
   PubMed Web of Science ®Google Scholar
• Cooper AM, Dalton DK, Stewart TA et al. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med.178(6), 2243–2247 (1993).
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J, Triebold KJ et al. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med.178, 2249–2254 (1993).
   PubMed Web of Science ®Google Scholar
• Sugawara I, Yamada H, Li C et al. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol.47(5), 327–336 (2003).
   PubMed Web of Science ®Google Scholar
• Reiling N, Hölscher C, Fehrenbach A et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol.169, 3480–3484 (2002).
   PubMed Web of Science ®Google Scholar
• Drennan MB, Nicolle DMM, Quesniaux VFJ et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol.164(1), 49–57 (2004).
   PubMed Web of Science ®Google Scholar
• Abel B, Thieblemont N, Quesniaux VFJ et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol.169, 3155 (2002).
   PubMed Web of Science ®Google Scholar
• Branger J, Leemans JC, Florquin S et al. Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int. Immunol.16(3), 509–516 (2004).
   PubMed Web of Science ®Google Scholar
• Kamath AB, Alt J, Debbabi H, Behar SM. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect. Immun.71(7), 4112–4118 (2003).
   PubMed Web of Science ®Google Scholar
• Shinozawa Y, Matsumoto T, Uchida KOU et al. Role of interferon-γ in inflammatory responses in murine respiratory infection with Legionella pneumophila. J. Med. Microbiol.51(3), 225–230 (2002).
   PubMed Web of Science ®Google Scholar
• Brieland JK, Remick DG, Freeman PT et al.In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor α and nitric oxide. Infect. Immun.63(9), 3253–3258 (1995).
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Bagby GJ, Schmidt RA, Nelson S. Antibody mediated depletion of tumor necrosis factor-α impairs pulmonary host defenses to Legionella pneumophila. J. Infect. Dis.176(4), 1019–1028 (1997).
   PubMed Web of Science ®Google Scholar
• Brieland JK, Remick DG, LeGendre ML, Engleberg NC, Fantone JC. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12. Infect. Immun.66(1), 65–69 (1998).
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Martin TR. Roles for tumor necrosis factor α and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Infect. Immun.64(8), 3236–3243 (1996).
   PubMed Web of Science ®Google Scholar
• Girard R, Pedron T, Uematsu S et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell. Sci.116(2), 293–302 (2003).
   PubMed Web of Science ®Google Scholar
• Swanson MS, Hammer BK. Legionella pneumophila pathogenesis: a fateful journey from amoebae to macrophages. Annu. Rev. Microbiol.54(1), 567–613 (2000).
   PubMed Web of Science ®Google Scholar
• Akamine M, Higa F, Arakaki N et al. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect. Immun.73(1), 352–361 (2005).
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Kobayashi T, Gomi K et al. Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses. J. Immunol.172(3), 1727–1734 (2004).
   PubMed Web of Science ®Google Scholar
• Newton CA, Perkins I, Widen RH, Friedman H, Klein TW. Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice. Infect. Immun.75(1), 146–151 (2007).
   PubMed Web of Science ®Google Scholar
• Archer KA, Roy CR. MyD88-dependent responses involving Toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires’ disease. Infect. Immun.74(6), 3325–3333 (2006).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Smith KD, Aderem A, Skerrett SJ. Myeloid differentiation primary response gene (88)- and Toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J. Infect. Dis.193(12), 1693–1702 (2006).
   PubMed Web of Science ®Google Scholar
• Sporri R, Joller N, Albers U, Hilbi H, Oxenius A. MyD88-dependent IFN-γ production by NK cells is key for control of Legionella pneumophila infection. J. Immunol.176(10), 6162–6171 (2006).
   PubMed Web of Science ®Google Scholar
• Fuse ET, Tateda K, Kikuchi Y et al. Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J. Med. Microbiol.56(3), 305–312 (2007).
   PubMed Web of Science ®Google Scholar
• Lettinga K, Florquin S, Speelman P et al. Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model. J. Infect. Dis.186(4), 570–573 (2002).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Verbon A, Janer M et al. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease. Proc. Natl Acad. Sci. USA102(7), 2487–2489 (2005).
   PubMed Web of Science ®Google Scholar
• Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol.3(4), 354–359 (2002).
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Liggitt HD, Hajjar AM et al. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol. Lung Cell. Mol. Physiol.287(1), L143–L152 (2004).
   Web of Science ®Google Scholar
• Aliprantis AO, Yang R-B, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science285(5428), 736–739 (1999).
   PubMed Web of Science ®Google Scholar
• Firoved AM, Ornatowski W, Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect. Immun.72(9), 5012–5018 (2004).
   PubMed Web of Science ®Google Scholar
• Flo TH, Ryan L, Latz E et al. Involvement of Toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem.277(38), 35489–35495 (2002).
   PubMed Web of Science ®Google Scholar
• Epelman S, Stack D, Bell C et al. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol.173(3), 2031–2040 (2004).
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J. Immunol.172(6), 3377–3381 (2004).
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol.292(1), L312–L322 (2007).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity11(4), 443–451 (1999).
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Williams WA, Missiakas D. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc. Natl Acad. Sci. USA103(37), 13831–13836 (2006).
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Tawaratsumida K, Kariya H et al. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int. Immunol.18(2), 355–362 (2006).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol.165(10), 5392–5396 (2000).
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Lien E, Ingalls RR et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol.163(1), 1–5 (1999).
   PubMed Web of Science ®Google Scholar
• Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev.18(3), 521–540 (2005).
   PubMed Web of Science ®Google Scholar
• Kim M, Goldstein E, Lewis JP, Libbert W, Warshauer D. Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation, and destruction. J. Infect. Dis.133(3), 310–320 (1976).
   PubMed Web of Science ®Google Scholar
• Rehm SR, Gross GN, Pierce AK. Early bacterial clearance from murine lungs: species-dependent phagocyte response. J. Clin. Invest.66(2), 194–199 (1980).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Zorn B, Senna JPM, Fiette L et al. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect. Immun.73(3), 1847–1851 (2005).
   PubMed Web of Science ®Google Scholar
• Campbell GD Jr. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia. Chest115(90001), 14S–18S (1999).
   Google Scholar
• BernsteinJM. Treatment of community-acquired pneumonia. IDSA guidelines. Chest115(90001), 9S–13S (1999).
   Google Scholar
• Musher DM, Alexandraki I, Graviss EA et al. Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine79(4), 210–221 (2000).
   PubMed Web of Science ®Google Scholar
• Echchannaoui H, Frei K, Schnell C et al. Toll-like receptor-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis.186(6), 798–806 (2002).
   PubMed Web of Science ®Google Scholar
• Koedel U, Angele B, Rupprecht T et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol.170(1), 438–444 (2003).
   PubMed Web of Science ®Google Scholar
• Malley R, Henneke P, Morse SC et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl Acad. Sci. USA100(4), 1966–1971 (2003).
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Paludan SR, Kilian M, Ostergaard L. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol.80(2), 267–277 (2006).
   PubMed Web of Science ®Google Scholar
• Branger J, Knapp S, Weijer S et al. Role of Toll-like receptor 4 in Gram-positive and Gram-negative pneumonia in mice. Infect. Immun.72(2), 788–794 (2004).
   PubMed Web of Science ®Google Scholar
• Knapp S, Wieland CW, Van C et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol.172(5), 3132–3138 (2004).
   PubMed Web of Science ®Google Scholar
• Mann P, Kennett M, Harvill E. Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J. Infect. Dis.189(5), 833–836 (2004).
   PubMed Web of Science ®Google Scholar
• Wang X, Moser C, Louboutin J-P et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol.168(2), 810–815 (2002).
   PubMed Web of Science ®Google Scholar
• Lee JS, Frevert CW, Matute-Bello G et al. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol.289(5), L731–L738 (2005).
   PubMed Web of Science ®Google Scholar
• Jeyaseelan S, Manzer R, Young SK et al. Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli. J. Immunol.175(11), 7484–7495 (2005).
   PubMed Web of Science ®Google Scholar
• Jeyaseelan S, Young SK, Fessler MB et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol.178(5), 3153–3160 (2007).
   PubMed Web of Science ®Google Scholar
• Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol. Rev.219(1), 167–186 (2007).
   PubMed Web of Science ®Google Scholar
• Orange JS, Geha RS. Finding NEMO: genetic disorders of NF-κB activation. J. Clin. Invest.112(7), 983–985 (2003).
   PubMed Web of Science ®Google Scholar
• Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-κB-mediated immunity in man. Curr. Opin. Immunol.16(1), 34–41 (2004).
   PubMed Web of Science ®Google Scholar
• Geha RS, Notarangelo LD, Casanova J-L et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol.120(4), 776–794 (2007).
   PubMed Web of Science ®Google Scholar
• Hill AVS. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet.40(1), 469–486 (2006).
   PubMed Web of Science ®Google Scholar
• Frodsham AJ, Hill AVS. Genetics of infectious diseases. Hum. Mol. Genet.13(Suppl. 2), R187–R194 (2004).
   Google Scholar
• Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin. Genet.58(4), 250–264 (2000).
   PubMed Web of Science ®Google Scholar
• Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin. Sci.114(5), 347–360 (2008).
   PubMed Web of Science ®Google Scholar
• Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun.68(11), 6398–6401 (2000).
   PubMed Web of Science ®Google Scholar
• Barber RC, Chang LY, Arnoldo BD et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res.4(4), 250–255 (2006).
   PubMedGoogle Scholar
• Child NJ, Yang IA, Pulletz MC et al. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans.31(Pt 3), 652–653 (2003).
   PubMed Web of Science ®Google Scholar
• Feterowski C, Emmanuilidis K, Miethke T et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology109(3), 426–431 (2003).
   PubMed Web of Science ®Google Scholar
• Schroder NWJ, Diterich I, Zinke A et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage lyme disease. J. Immunol.175(4), 2534–2540 (2005).
   PubMed Web of Science ®Google Scholar
• Ogus AC, Yoldas B, Ozdemir T et al. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J.23(2), 219–223 (2004).
   PubMed Web of Science ®Google Scholar
• Yim J-J, Ding L, Schaffer AA et al. A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences. FEMS Immunol. Med. Microbiol.40(2), 163–169 (2004).
   PubMedGoogle Scholar
• Yim JJ, Lee HW, Lee HS et al. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun.7(2), 150–155 (2006).
   PubMed Web of Science ®Google Scholar
• Kang T-J, Chae G-T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol.31(1), 53–58 (2001).
   PubMed Web of Science ®Google Scholar
• Ben-Ali M, Barbouche M-R, Bousnina S, Chabbou A, Dellagi K. Toll-Like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol.11(3), 625–626 (2004).
   PubMedGoogle Scholar
• Malhotra D, Relhan V, Reddy BSN, Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum. Genet.116(5), 413–415 (2005).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Misch EA, Dunstan SJ et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J. Immunol.37(8), 2280–2289 (2007).
   PubMed Web of Science ®Google Scholar
• Misch E, MacDonald M, Ranjit C et al. Human TLR 1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl. Trop. Dis.2(5), e231 (2008).
   PubMed Web of Science ®Google Scholar
• Ma X, Liu Y, Gowen BB et al. Full-exon resequencing reveals Toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE2(12), e1318 (2007).
   PubMedGoogle Scholar
• Boshuizen HC, Neppelenbroek SE, van Vliet H et al. Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J. Infect. Dis.184(4), 515–518 (2001).
   PubMed Web of Science ®Google Scholar
• Den Boer JW, Yzerman EP, Schellekens J et al. A large outbreak of Legionnaires’ disease at a flower show, The Netherlands, 1999. Emerg. Infect. Dis.8(1), 37–43. (2002).
   PubMed Web of Science ®Google Scholar
• Lettinga KD, Verbon A, Weverling GJ et al. Legionnaires’ disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg. Infect. Dis.8(12), 1448–1454. (2002).
   PubMed Web of Science ®Google Scholar
• Dunstan S, Hawn T, Hue N et al. Host susceptibility and clinical outcomes in Toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis.191(7), 1068–1071 (2005).
   PubMed Web of Science ®Google Scholar
• Moens L, Verhaegen J, Pierik M et al. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect.9(1), 15–20 (2007).
   PubMed Web of Science ®Google Scholar
• Cooke GS, Segal S, Hill AVS et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med.347(24), 1978–1980 (2002).
   PubMedGoogle Scholar
• Khor CC, Chapman SJ, Vannberg FO et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet.39(4), 523–528 (2007).
   PubMed Web of Science ®Google Scholar
• Nejentsev S, Thye T, Szeszko JS et al. Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat. Genet.40(3), 261–262 (2008).
   PubMed Web of Science ®Google Scholar
• Hawn TR, Dunstan SJ, Thwaites GE et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis.194(8), 1127–1134 (2006).
   PubMed Web of Science ®Google Scholar
• Casanova J-L, Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med.202(2), 197–201 (2005).
   PubMed Web of Science ®Google Scholar
• WHO. Burden of Disease Project. World Health Organization, Geneva, Switzerland (2005).
   Google Scholar
• Mizgerd JP. Lung infection – a public health priority. PLoS Med.3(2), e76 (2006).
   PubMedGoogle Scholar
• Romagne F. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov. Today12(1–2), 80–87 (2007).
   PubMed Web of Science ®Google Scholar
• Beutner KR, Tyring SK, Trofatter KF Jr et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob. Agents Chemother.42(4), 789–794 (1998).
   PubMed Web of Science ®Google Scholar
• Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov.5(6), 471–484 (2006).
   PubMed Web of Science ®Google Scholar
• Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol.5(10), 975–979 (2004).
   PubMed Web of Science ®Google Scholar
• Liew FY, Xu D, Brint EK, O’Neill LAJ. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol.5(6), 446–458 (2005).
   PubMed Web of Science ®Google Scholar
• Moore CE, Segal S, Berendt AR, Hill AVS, Day NPJ. Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin. Diagn. Lab. Immunol.11(6), 1194–1197 (2004).
   PubMedGoogle Scholar
• Everett B, Cameron B, Li H et al. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun.8(8), 699–702 (2007).
   PubMed Web of Science ®Google Scholar
• Newport MJ, Allen A, Awomoyi AA et al. The Toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis84(6), 347–352 (2004).
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Kibiki G, Netea M, Dolmans W, van der Ven A. The Toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS21, 1375–1377 (2007).
   PubMed Web of Science ®Google Scholar
• Hawn T, Dunstan S, Thwaites G et al. A polymorphism in Toll–interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis.194(8), 1127–1134 (2006).
   PubMed Web of Science ®Google Scholar